Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk that is approved by the U.S. Food ...

Novo Nordisk and Vivani Medical are testing a small implant that releases semaglutide over several months, potentially ...

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...

"After billions of doses, we now have an extraordinary amount of scientific evidence." The post Huge Survey Finds the Truth ...

If you have diabetes, your health care provider may recommend Trulicity or Mounjaro, two medications approved by the U.S.

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.

EMA’s positive opinion would lower the approved age for Imvanex from 12 years to 2 years for smallpox, mpox, and vaccinia virus disease.

Peptide may not yet be the 2026 Oxford Word of the Year, but it must surely be in the running. From your friendly ...

Approval was supported by IRAKLIA Phase III non-inferiority data comparing on-body injector subcutaneous isatuximab to weight-based IV, both combined with pomalidomide and dexamethasone in R/R myeloma ...